Sensus Healthcare, Inc.

Sensus Healthcare, Inc.

SRTSยทNASDAQ

$3.09

-2.8%
HealthcareMedical - Devices

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

At a Glance

Live Snapshot
Market Cap$50.87M
EPS-0.4700
P/E Ratio-8.42
Earnings Date07/30/2026
3Y-7.0%
5Y+89.0%
10Y+180.0%
3Y-43.0%
5Y-24.0%
10Y+35.0%
3Y-
5Y+124.0%
10Y+215.0%
srts

Sensus Healthcare, Inc. Funding & Solvency Profile

SRTS ยท NASDAQ
Cash & Cash Equivalents22.08M
Net Receivables6.04M
Inventory14.56M
Other Current Assets1.68M
Total Current Assets46 M
Property, Plant & Equipment2.43M
Goodwill & Intangible Assets0.00
Long-Term Investments0.00
Other Non-Current Assets640.00K
Total Non-Current Assets3 M
Total Assets
53.04M

Financial Health Analysis

Current Ratio

9.72x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.10x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

41 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

87% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Sensus Healthcare, Inc. Balance Sheet

SRTS โ€ข NASDAQ

Sensus Healthcare, Inc. Balance SheetDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014
ASSETS
CURRENT ASSETS
22.1M
22.1M
23.1M
25.5M
14.5M
14.9M
8.1M
12.5M
10.1M
5M
5.1M
4.5M
0.0
0.0
0.0
0.0
0.0
0.0
7.4M
2.9M
1.1M
6.5M
0.0
0.0
22.1M
22.1M
23.1M
25.5M
14.5M
14.9M
15.5M
15.4M
11.2M
11.5M
5.1M
4.5M
6M
19.7M
10.6M
17.3M
12.1M
3.8M
14M
13.1M
5M
3.1M
2.1M
407.6K
6M
19.7M
10.6M
17.3M
12.1M
3.8M
14M
13.1M
5M
3.1M
2.1M
407.6K
14.6M
10.1M
11.9M
3.5M
1.8M
4.4M
3M
1.6M
1.2M
1.3M
998.9K
844.1K
1.5M
3.3M
3M
6.3M
2.6M
2.1M
1.5M
1.8M
567K
900.7K
122.8K
48.3K
1.7M
1.5M
888K
660K
268K
0.0
0.0
0.0
0.0
0.0
310K
0.0
45.9M
56.7M
49.5M
53.2M
31.2M
25.2M
34M
31.9M
17.9M
16.8M
8.6M
5.8M
NON-CURRENT ASSETS
2.4M
2.6M
1.2M
1.2M
774K
2.4M
2.5M
891K
394.1K
433.4K
320.7K
260.5K
0.0
0.0
0.0
50K
146K
338K
337.4K
433.7K
530.1K
626.5K
722.9K
819.3K
0.0
0.0
0.0
50K
146K
338K
337.4K
433.7K
530.1K
626.5K
722.9K
819.3K
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.1M
0.0
0.0
4.1M
2.2M
2.1M
1.7M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
640K
652K
804K
492K
75K
69K
101.6K
24.3K
24.3K
24.3K
24.3K
24.3K
7.1M
5.4M
4.2M
3.5M
995K
2.8M
2.9M
1.3M
948.5K
2.2M
1.1M
1.1M
53M
62.2M
53.7M
56.7M
32.2M
28M
36.9M
33.3M
18.8M
18.9M
9.6M
6.9M
LIABILITIES
CURRENT LIABILITIES
3.3M
4.8M
2.8M
6.4M
4.1M
0.0
4.8M
5.2M
4.1M
2.8M
2.3M
1.1M
3.3M
4.8M
2.8M
5.5M
4.1M
0.0
4.8M
5.2M
4.1M
2.8M
2.3M
1.1M
0.0
0.0
37K
890K
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
262K
0.0
0.0
0.0
51K
0.0
0.0
0.0
0.0
0.0
422.7K
375K
0.0
204K
187K
190K
174K
303K
309.5K
0.0
0.0
0.0
0.0
0.0
0.0
0.0
37K
890K
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
842K
541K
657K
693K
1.2M
1.5M
1.2M
722K
652.2K
853.8K
890.2K
1.2M
275K
329K
538K
403K
508K
3.1M
187.5K
136.2K
146.7K
40.5K
48.4K
47.6K
4.7M
5.9M
4.2M
7.7M
6M
4.9M
6.5M
6M
7.1M
3.7M
3.7M
2.8M
NON-CURRENT LIABILITIES
209K
0.0
0.0
0.0
0.0
267K
0.0
0.0
2.2M
0.0
0.0
0.0
10K
55K
60K
139K
262K
579K
1.3M
766.7K
73.1K
16.3K
45.8K
51K
0.0
0.0
0.0
0.0
0.0
0.0
-1.1M
0.0
-4.4M
0.0
0.0
0.0
-209K
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
219K
453K
656K
969K
262K
1.7M
2.5M
766.7K
73.1K
16.3K
45.8K
51K
209K
602K
783K
1M
174K
1.1M
1.4M
0.0
0.0
0.0
0.0
0.0
4.9M
6.3M
4.9M
8.7M
6.2M
6.5M
8.9M
6.8M
7.2M
3.7M
3.7M
2.8M
SHAREHOLDERS' EQUITY
-3.9M
-3.6M
-3.5M
-3.4M
-325K
-310K
-252.6K
-133.8K
-133.8K
0.0
0.0
0.0
169K
169K
169K
169K
167K
166K
165.4K
161.5K
135.2K
135.5K
428.0
408.0
46.1M
45.8M
45.4M
45M
44.1M
43.7M
43.3M
40M
23.2M
22.9M
13.4M
11.3M
5.7M
13.4M
6.8M
6.3M
-17.9M
-22.1M
-15.2M
-13.5M
-11.5M
-7.8M
-7.4M
-7.2M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-858K
-514.1K
-587.2K
-669.9K
-494.8K
48.1M
55.8M
48.8M
48.1M
26M
21.5M
28M
26.5M
11.7M
15.3M
5.9M
4.1M
48.1M
55.8M
48.8M
48.1M
26M
21.5M
28M
26.5M
11.7M
15.3M
5.9M
4.1M
SUMMARY
53M
62.2M
53.7M
56.7M
32.2M
28M
36.9M
33.3M
18.8M
18.9M
9.6M
6.9M
0.0
0.0
0.0
0.0
0.0
0.0
7.4M
2.9M
1.1M
7.6M
0.0
0.0
680K
602K
783K
1M
225K
1.4M
1.4M
0.0
2.2M
0.0
422.7K
375K
-21.4M
-21.5M
-22.4M
-24.5M
-14.3M
-13.5M
-6.7M
-12.5M
-7.9M
-5M
-4.6M
-4.2M
16,440,036
16,440,036
16,440,036
16,440,036
16,440,036
16,440,036
16,440,036
16,440,036
16,440,036
16,440,036
16,440,036
16,440,036

SEC Filings

SRTS - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

June 02, 2026
May 29, 2026
2026
10-Q

10-Q 2026 Q1

Q1

May 13, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

May 07, 2026
May 07, 2026
2026
DEF 14A

DEF 14A 2026

N/A

April 29, 2026
May 29, 2026
2026
10-K

10-K 2025 FY

FY

March 04, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

February 12, 2026
February 12, 2026
2026
8-K

8-K 2026

N/A

January 20, 2026
January 13, 2026
2026
8-K

8-K 2026

N/A

January 12, 2026
January 05, 2026
2026
8-K

8-K 2025

N/A

November 13, 2025
November 10, 2025
2025
10-Q

10-Q 2025 Q3

Q3

November 12, 2025
September 30, 2025
2025
Showing 1 to 10 of 137 filings